Q3 FY2026 · ended Sep 30, 2026 · Revenue $6.58B, +1.0% YoY · Filed Oct 20, 2026
3M Company (MMM) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $6.6 billion and net income of $1.4 billion. Free cash flow was $230.0 million. As of Sep 30, 2026 it held $4.8 billion in cash and investments and $15.6 billion in total debt.
Revenue
$6.58B
+1.0% vs year-ago quarter
Net income
$1.37B
+64.6% vs year-ago quarter
Operating cash flow
$486.00M
-72.3% vs year-ago quarter
Free cash flow
$230.00M
-85.0% vs year-ago quarter
EPS
$2.63
+69.7% vs year-ago quarter
Dividend per share
$0.78
+6.8% vs year-ago quarter
Shares outstanding
516.73M
-2.7% vs year-ago quarter
Net cash
$-10.76B
Q3 FY2026
Operating margin
18.8%
TTM
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MMM (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- St Paul, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 66740
- Former names
- MINNESOTA MINING & MANUFACTURING CO (until Feb 6, 2002)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
- West Pharmaceutical Services Inc WST
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $6.6B | $6.5B | $6.0B | $6.1B | $6.5B |
| Operating income | $1.6B | $984.0M | $1.4B | $796.0M | $1.4B |
| Net income | $1.4B | $933.0M | $653.0M | $577.0M | $834.0M |
| Diluted EPS | $2.63 | $1.78 | $1.23 | $1.07 | $1.55 |
| Operating cash flow | $486.0M | $986.0M | $574.0M | $1.6B | $1.8B |
| Free cash flow | $230.0M | $763.0M | $349.0M | $1.3B | $1.5B |
| Total assets | $39.5B | $34.9B | $35.4B | $37.7B | $37.6B |
| Total liabilities | $34.4B | $31.9B | $32.1B | $33.0B | $32.9B |
| Stockholders' equity | $4.1B | $3.0B | $3.3B | $4.7B | $4.6B |
| Cash and investments | $4.8B | $3.0B | $3.7B | $5.2B | $4.7B |
| Total debt | $15.6B | $11.5B | $11.5B | $13.1B | $13.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Other events
|
Nov 4, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Oct 20, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Aug 19, 2026 | Aug 17, 2026 |
All 1001 3M Company SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.